OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript
OraSure Technologies is currently navigating a critical transition period characterized by a 99.9% year-over-year revenue decline in 2026Q1 as pandemic-era demand evaporates. The company's inability to pivot its cost structure, evidenced by an operating margin...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 5, 2026 | $0.09+133.3% vs -$0.27 | $31M+5.3% vs $29M |
Q2 2026 May 6, 2026 | -$0.32-39.1% vs -$0.23 | $28M+0.8% vs $28M |
Q1 2026 Feb 25, 2026 | -$0.27-58.8% vs -$0.17 | $27M+1.0% vs $26M |
Q4 2025 Nov 5, 2025 | -$0.19-18.8% vs -$0.16 | $27M-7.0% vs $29M |
OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript
OraSure Technologies NASDAQ: OSUR reported second-quarter revenue of $30.6 million, exceeding its guidance range and rising 9.7% sequentially, as stronger public-health diagnostics demand and growth in sample-management products supported results.
BETHLEHEM, Pa. , Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended June 30, 2026. "Our Q2 results demonstrate continued progress in our return-to-growth trajectory, with revenue of $30.
BETHLEHEM, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended June 30, 2026.
Benchmark OSUR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for OraSure Technologies, Inc. (OSUR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $3.99 | $274.71M | -4.24 | -38.1% | -59.76% | -18.3% | — | |
| $10.34 | $705.09M | -0.62 | -1.89% | -39.2% | -55.3% | — | |
| $522.02 | $41.18B | 39.91 | 10.42% | 25.03% | 71.96% | — | |
| $103.53 | $180.32B | 27.83 | 5.67% | 13.91% | 12.09% | — | |
| $182.52 | $50.29B | 31.31 | 8.23% | 4.52% | 3.79% | — | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — |
OraSure Technologies, Inc. (OSUR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
OraSure Technologies, Inc. (OSUR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 5, 2026·SEC
Jun 11, 2026·SEC
May 6, 2026·SEC
Get notified when OSUR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
OraSure Technologies, Inc. (OSUR) stock FAQ — growth, dividends, profitability & financials explained
OraSure Technologies, Inc. (OSUR) reported $112.4M in revenue for fiscal year 2025. This represents a 64% increase from $68.7M in 1996.
OraSure Technologies, Inc. (OSUR) saw revenue decline by 38.1% over the past year.
OraSure Technologies, Inc. (OSUR) reported a net loss of $49.1M for fiscal year 2025.
OraSure Technologies, Inc. (OSUR) has a return on equity (ROE) of -18.3%. Negative ROE indicates the company is unprofitable.
OraSure Technologies, Inc. (OSUR) had negative free cash flow of $62.9M in fiscal year 2025, likely due to heavy capital investments.